Suppr超能文献

经病理证实的重度主动脉瓣狭窄病因对行主动脉瓣置换术患者中期结局的临床影响。

Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement.

机构信息

Department of Cardiology, Hokkaido Ohno Memorial Hospital, Sapporo, Japan.

Department of Laboratory Medicine, Kokura Memorial Hospital, Kitakyushu, Japan.

出版信息

PLoS One. 2020 Mar 10;15(3):e0229721. doi: 10.1371/journal.pone.0229721. eCollection 2020.

Abstract

BACKGROUND

The use of transcatheter or surgical aortic valve replacement (AVR) for severe aortic stenosis (AS) has considerably increased in recent years. However, the association between AS etiology and mid-term clinical outcomes after surgical AVR has not been fully investigated.

METHODS AND RESULTS

We retrospectively included 201 patients (mean age, 75 years; 43%, men) who underwent surgical AVR for severe native AS (aortic valve area ≤1.0 cm2 on preoperative transthoracic echocardiography examination). The following valve etiologies were postoperatively identified on pathological examination: post-inflammatory (n = 28), congenital (n = 35), and calcific/degenerative (n = 138). The median follow-up interval was 4.1 years following surgical AVR. Of the 201 patients, 27% were asymptomatic, 40% had a history of heart failure, and 11% underwent previous heart surgery. The cumulative incidence of cardiac events (all-cause death, aortic valve deterioration requiring repeated AVR, and hospitalization for heart failure) and combined adverse events, which included non-fatal stroke, unplanned coronary revascularization, pacemaker implantation, and gastrointestinal bleeding along with cardiac events, was significantly higher in the calcific/degenerative group (p = 0.02 and p = 0.02, respectively). In multivariate analysis adjusted for age, sex, renal function, heart failure, atrial fibrillation, concomitant surgical procedures, and EuroSCORE II, AS etiology was independently associated with an increased risk of combined adverse events (congenital vs. post-inflammatory: hazard ratio [HR], 4.13; p = 0.02 and calcific/degenerative vs. post-inflammatory: HR, 5.69; p = 0.002).

CONCLUSIONS

Pathology-proven AS etiology could aid in predicting the mid-term outcomes after surgical AVR, supporting the importance of accurate identification of severe AS etiology with or without postoperative pathological examination.

摘要

背景

近年来,经导管或外科主动脉瓣置换术(AVR)治疗严重主动脉瓣狭窄(AS)的应用显著增加。然而,外科 AVR 后 AS 病因与中期临床结果之间的关系尚未得到充分研究。

方法和结果

我们回顾性纳入了 201 名(平均年龄 75 岁;43%为男性)接受外科 AVR 治疗严重原发性 AS(术前经胸超声心动图检查主动脉瓣面积≤1.0cm2)的患者。术后病理检查确定了以下瓣膜病因:炎症后(n=28)、先天性(n=35)和钙化/退行性(n=138)。外科 AVR 后中位随访时间为 4.1 年。201 名患者中,27%无症状,40%有心力衰竭病史,11%曾接受过心脏手术。心脏事件(全因死亡、需要再次 AVR 的主动脉瓣恶化以及因心力衰竭住院)和联合不良事件(包括非致命性卒中、计划外冠状动脉血运重建、起搏器植入以及胃肠道出血伴心脏事件)的累积发生率在钙化/退行性组显著更高(p=0.02 和 p=0.02)。多变量分析调整了年龄、性别、肾功能、心力衰竭、心房颤动、合并手术程序和 EuroSCORE II 后,AS 病因与联合不良事件风险增加独立相关(先天性 vs. 炎症后:风险比[HR],4.13;p=0.02 和钙化/退行性 vs. 炎症后:HR,5.69;p=0.002)。

结论

经病理证实的 AS 病因有助于预测外科 AVR 后的中期结果,支持在有或无术后病理检查的情况下准确识别严重 AS 病因的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8c/7064191/5be07b3303bb/pone.0229721.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验